HighVista Strategies’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.59M Buy
73,189
+46,788
+177% +$1.45M 0.71% 47
2025
Q4
$739K Sell
26,401
-17,680
-40% -$530K 0.19% 125
2025
Q3
$1.32M Sell
44,081
-8,863
-17% -$250K 0.32% 100
2025
Q2
$1.51M Sell
52,944
-17,818
-25% -$530K 0.56% 63
2025
Q1
$2.34M Buy
70,762
+16,316
+30% +$532K 0.9% 24
2024
Q4
$1.57M Buy
+54,446
New +$1.57M 0.58% 61

Other funds holding ALKS

HighVista Strategies's ALKS Position: Q1 2026 in Review

HighVista Strategies increased its Alkermes (ALKS) stake by 177% in Q1 2026, buying an estimated $1.45M and bringing the position to 73,189 shares worth $2.59M. The position accounts for 0.71% of the portfolio, ranked #47.

HighVista Strategies first reported a position in ALKS in Q4 2024 and has held it in 6 quarters since. 388 funds tracked by Wall St. Rank hold ALKS as of Q1 2026.

  • HighVista Strategies held 73,189 shares of Alkermes worth $2.59M as of Q1 2026.
  • HighVista Strategies bought 46,788 Alkermes shares in Q1 2026, an estimated $1.45M.
  • Alkermes made up 0.71% of HighVista Strategies's portfolio in Q1 2026, its #47 holding.
  • HighVista Strategies first reported a position in Alkermes in Q4 2024 and has held it in 6 quarters since.
  • 388 funds tracked by Wall St. Rank held Alkermes as of Q1 2026.

Based on HighVista Strategies's 13F filing for Q1 2026, filed 15 May 2026.